Two Dose Levels of Privigen in Pediatric CIDP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Two Dose Levels of Privigen in Pediatric CIDP — Stella

Recruiting

Back to Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(9 sites)

United States

Phoenix Children's Hospital, Phoenix, Arizona

Children's Hospital of Los Angeles, Los Angeles, California

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Akron Children's Hospital, Akron, Ohio

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Phase

Post-approval study

Sponsor

CSL Behring

Enrollment target

~30 participants

Started

February 2019

Primary completion

December 2029

Age range

2 Years – 17 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov